VAM
AMRI
Visium Asset Management’s Albany Molecular Research Inc AMRI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-2,009,452
| Closed | -$30.7M | – | 524 |
|
2016
Q1 | $30.7M | Sell |
2,009,452
-89,348
| -4% | -$1.37M | 0.52% | 40 |
|
2015
Q4 | $41.7M | Sell |
2,098,800
-1,201,200
| -36% | -$23.8M | 0.63% | 28 |
|
2015
Q3 | $57.5M | Buy |
3,300,000
+100,000
| +3% | +$1.74M | 0.79% | 21 |
|
2015
Q2 | $64.7M | Buy |
3,200,000
+1,820,000
| +132% | +$36.8M | 0.92% | 15 |
|
2015
Q1 | $24.3M | Sell |
1,380,000
-1,820,000
| -57% | -$32M | 0.36% | 55 |
|
2014
Q4 | $52.1M | Buy |
3,200,000
+2,000,000
| +167% | +$32.6M | 0.74% | 21 |
|
2014
Q3 | $26.5M | Sell |
1,200,000
-970,000
| -45% | -$21.4M | 0.39% | 43 |
|
2014
Q2 | $43.7M | Sell |
2,170,000
-980,000
| -31% | -$19.7M | 0.68% | 18 |
|
2014
Q1 | $58.6M | Hold |
3,150,000
| – | – | 0.95% | 14 |
|
2013
Q4 | $31.8M | Buy |
3,150,000
+1,115,000
| +55% | +$11.2M | 0.62% | 28 |
|
2013
Q3 | $26.2M | Buy |
+2,035,000
| New | +$26.2M | 0.59% | 33 |
|